OVAS - オバサイエンス （OvaScience Inc.）OVASのニュース
INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of OvaScience, Inc. Scheduled For A Shareholder Vote On December 4, 2018 - OVAS 2018-11-16 PR Newswire
NEW YORK , Nov. 16, 2018 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating OvaScience, Inc. ("OvaScience" or the "Company"…
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing 2018-11-01 Business Wire
New Commitment by Great Point Partners Brings Proceeds of Transactions to $87 Million Current OvaScience Shareholders to Benefit from Improved Exchange Ratio OvaScience SM (Nasdaq:OVAS) and privately-held Millendo Therapeutics, Inc. , a cli…
INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of OvaScience, Inc. Scheduled For A Shareholder Vote On December 4, 2018 - OVAS 2018-11-16 PR Newswire
NEW YORK , Nov. 16, 2018 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating OvaScience, Inc. ("OvaScience" or the "Company"…
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing 2018-11-01 Business Wire
New Commitment by Great Point Partners Brings Proceeds of Transactions to $87 Million Current OvaScience Shareholders to Benefit from Improved Exchange Ratio OvaScience SM (Nasdaq:OVAS) and privately-held Millendo Therapeutics, Inc. , a cli…
INVESTOR ALERT: Monteverde & Associates PC Is Investigating The Acquisition Of OvaScience, Inc. Scheduled For A Shareholder Vote On December 4, 2018 - OVAS 2018-11-16 PR Newswire
NEW YORK , Nov. 16, 2018 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating OvaScience, Inc. ("OvaScience" or the "Company"…
OvaScience and Millendo Therapeutics Provide Update on Merger Agreement and Financing 2018-11-01 Business Wire
New Commitment by Great Point Partners Brings Proceeds of Transactions to $87 Million Current OvaScience Shareholders to Benefit from Improved Exchange Ratio OvaScience SM (Nasdaq:OVAS) and privately-held Millendo Therapeutics, Inc. , a cli…